David Gomez Jimenez (Former)
1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Single-cell analysis of myeloid cells in HPV+ tonsillar cancer
(
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
-
Mark
Targeted spatial proteomic analysis of CD8+ T- and myeloid cells in tonsillar cancer
(
- Contribution to journal › Article
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
(
- Contribution to journal › Article
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
(
- Contribution to journal › Article
-
Mark
Single-cell analysis of myeloid cells in HPV+ tonsillar cancer
2022) In BioRxiv(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Dissection of the tonsillar cancer immune microenvironment : Perspectives of the myeloid APC – T-cell axis
2022)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Tonsillar cancer with high cd8+ t‐cell infiltration features increased levels of dendritic cells and transcriptional regulation associated with an inflamed tumor microenvironment
(
- Contribution to journal › Article
-
Mark
Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes
(
- Contribution to journal › Article